LivaNova PLCLIVN财报
Nasdaq · 医疗保健 · 电子医疗与电疗设备
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| BlackRock, Inc. | 13.80% | 7.4M | — | 2024-01-23 |
| PRIMECAP Management Company | 10.75% | 5.8M | ▲ +0.68pp | 2024-02-12 |
| Integrated Core Strategies | 5.10% | 2.7M | — | 2024-04-17 |
内部人交易
Net 90d: +$0 · buys $0 / sells $0时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-30 | Franco Poletti | President, Cardiopulmonary | Option exercise | 3.2K | $0.00 | $0 |
| 2026-03-30 | Ahmet Tezel | Chief Innovation Officer | Option exercise | 3.4K | $0.00 | $0 |
| 2026-03-30 | Stephanie Bolton | President, Global Epilepsy | Option exercise | 17.8K | $0.00 | $0 |
| 2026-03-30 | Alex Shvartsburg | Chief Financial Officer | Option exercise | 30.8K | $0.00 | $0 |
| 2026-03-30 | Vladimir Makatsaria | Chief Executive Officer | Option exercise | 21.0K | $0.00 | $0 |
| 2026-03-30 | Natalia Kozmina | Chief Human Resources Officer | Option exercise | 6.4K | $0.00 | $0 |
| 2026-03-11 | Franco Poletti | President, Cardiopulmonary | Option exercise | 2.1K | $57.60 | $123.3K |
1–7 of 7